What does the evidence say about Magnesium Glycinate Vs Magnesium Threonate?

The current Migaku evidence database contains 1 reusable source document for Magnesium Glycinate Vs Magnesium Threonate. This answer focuses on benefits, uncertainty, and practical interpretation. - This case series presents outcomes of the first 51 patients who participated in one such program and aims to add to preliminary evidence regarding the efficacy of a personalized multimodal integrative functional medicine approach to cognitive decline in the context of prior uncontrolled and ongoing controlled trials. [Kogan Mikhail (2026); evidence level 4] - Management of vascular risk factors (hypertension, hyperlipidemia, diabetes), tobacco and alcohol counseling, and hearing evaluation were conducted through participants’ primary clinicians, consistent with standard dementia prevention guidelines. [Kogan Mikhail (2026); evidence level 4] - As shown in, participants in the “improved” group were older and more likely to carry at least one APOE4 allele, whereas those in the “progressed” group were younger and started with lower baseline MoCA scores. [Kogan Mikhail (2026); evidence level 4] - 1 5 - 1 5 - Alzheimer’s disease (AD) and related dementias are significant public health challenges with limited treatment options. [Kogan Mikhail (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.